CHRNA2 and obesity disorder: However, no significant changes in iWAT weight or thermogenic gene expression were observed after 2 weeks of rivastigmine treatment (Fig 4J), suggesting that acute inhibition of acetylcholine degradation is insufficient to fully activate adipose CHRNA2 signaling, particularly in obesity, when beige adipocyte activity is repressed.